Chest Infections
-
Study demonstrates superior protection from mRNA influenza vaccine compared with standard-dose vaccines
Experts caution that further research is needed to evaluate the platform’s performance across multiple seasons and compare it with enhanced vaccines.
-
Bronchiectasis: Bridging the gap between guidelines and real-world care
The measure of a guideline is not how comprehensively it describes ideal care but how consistently its recommendations reach the patients who need them.
-
Riot medicine: Treating injuries from nonlethal force
At this CHEST 2026 session, a panel of experts will review the most common injury patterns seen in riot medicine and describe the most contemporary approach to their management.
-
New portable, accurate TB test may broaden access
International TB specialist Alfred A. Lardizabal, MD, said he believes the development will empower resource-limited communities by bringing TB diagnostic capacity closer.
-
Steroids in pneumonia: The end of an era?
Emerging data suggest a potential expanding role for corticosteroids in severe cases of community-acquired pneumonia, though it remains uncertain whether this approach should extend to nonsevere or outpatient settings.
-
DPP-1 inhibitors enter clinical practice
Sunjay R. Devarajan, MD, FCCP, and Anas Hadeh, MD, FCCP, said DPP-1 inhibitors are expected to become a new standard of care, with ongoing studies further defining their role in noncystic fibrosis bronchiectasis management.
-
Retrospective study confirms RSV, flu significantly increase hospitalization risk in pediatric patients
The study showed that children with comorbidities are at the highest risk, with a fivefold increase in severe outcomes.
-
Rapid RSV testing may reduce antibiotic use in pediatric respiratory infections
Riccardo Boracchini, MSc, said the study provides some of the strongest evidence to date that rapid diagnostic testing can reduce antibiotic use outside the hospital setting.
-
Link between viral pneumonia, lung cancer risk underlies importance of vaccination against respiratory infections
New data add weight to the case for protecting against respiratory viruses as part of lung cancer prevention.
-
Study supports early TB therapy to reduce sepsis mortality in HIV
The ATLAS team of researchers said that because typical sepsis treatment does not target TB, clinicians should consider immediate TB treatment for people with HIV-related sepsis.
-
Study finds triple combination modulator therapy reduces inflammation in CF
Valentino Bezzerri, PhD, discusses findings from a compassionate-use study examining the effects of elexacaftor/tezacaftor/ivacaftor on inflammation in patients with cystic fibrosis.
-
RSV hospitalization increases cardiorespiratory event, COPD exacerbation risk
Caihua Liang, MD, PhD, and Elizabeth Begier, MD, discuss the importance of prevention in light of data showing elevated risk for up to 180 days following the acute infection.
